Wenjin Xu

2.9k total citations
83 papers, 2.2k citations indexed

About

Wenjin Xu is a scholar working on Molecular Biology, Biomaterials and Biomedical Engineering. According to data from OpenAlex, Wenjin Xu has authored 83 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 17 papers in Biomaterials and 14 papers in Biomedical Engineering. Recurrent topics in Wenjin Xu's work include Nanoparticle-Based Drug Delivery (13 papers), Nanoplatforms for cancer theranostics (7 papers) and RNA Interference and Gene Delivery (6 papers). Wenjin Xu is often cited by papers focused on Nanoparticle-Based Drug Delivery (13 papers), Nanoplatforms for cancer theranostics (7 papers) and RNA Interference and Gene Delivery (6 papers). Wenjin Xu collaborates with scholars based in China, United States and United Kingdom. Wenjin Xu's co-authors include Shaoqin Gong, Yuling Xiao, Alireza Javadi, Hao Hong, Yunan Yang, Weibo Cai, Yin Zhang, Jonathan W. Engle, Srikanth Pilla and Herbert Chen and has published in prestigious journals such as Advanced Materials, Journal of Neuroscience and SHILAP Revista de lepidopterología.

In The Last Decade

Wenjin Xu

80 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wenjin Xu China 28 684 668 611 395 261 83 2.2k
Ningning Guo China 29 537 0.8× 819 1.2× 310 0.5× 325 0.8× 145 0.6× 102 2.6k
Silvia Dante Italy 31 628 0.9× 1.3k 2.0× 392 0.6× 496 1.3× 172 0.7× 112 2.8k
Wojciech G. Lesniak United States 34 477 0.7× 1.3k 1.9× 403 0.7× 438 1.1× 203 0.8× 83 3.6k
Karine Andrieux France 28 717 1.0× 1.1k 1.6× 1.4k 2.2× 470 1.2× 110 0.4× 68 3.2k
Juan Li China 28 1.0k 1.5× 642 1.0× 544 0.9× 684 1.7× 75 0.3× 105 2.6k
Zoya Leonenko Canada 33 915 1.3× 2.0k 3.0× 341 0.6× 539 1.4× 457 1.8× 101 3.8k
Probal Banerjee United States 41 952 1.4× 1.9k 2.8× 847 1.4× 907 2.3× 194 0.7× 103 4.6k
Keyin Liu China 35 836 1.2× 708 1.1× 534 0.9× 1.0k 2.6× 68 0.3× 116 3.1k

Countries citing papers authored by Wenjin Xu

Since Specialization
Citations

This map shows the geographic impact of Wenjin Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wenjin Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wenjin Xu more than expected).

Fields of papers citing papers by Wenjin Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wenjin Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wenjin Xu. The network helps show where Wenjin Xu may publish in the future.

Co-authorship network of co-authors of Wenjin Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Wenjin Xu. A scholar is included among the top collaborators of Wenjin Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wenjin Xu. Wenjin Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huang, Lihua, et al.. (2025). Construction and evaluation of a DOX@MOF-199-PDA–HA nanoparticle drug delivery system. New Journal of Chemistry. 49(22). 9520–9533. 1 indexed citations
2.
Zhou, Yun, Wenjin Xu, Shanshan Chen, et al.. (2025). tRF‐M2–Regulated Dopamine Receptor D2 Expression Attenuates Methamphetamine Reinstatement Behavior in Rats. Annals of the New York Academy of Sciences. 1556(1). e70127–e70127. 1 indexed citations
3.
Chen, Wenhui, Huan Deng, Yang Zhou, et al.. (2025). Double-Network Bilayer Hydrogel Loaded with Puerarin and Curcumin for Osteochondral Repair. ACS Omega. 10(37). 42282–42299. 2 indexed citations
4.
Deng, Huan, Yang Zhou, Lin Yang, et al.. (2025). Study of conductive nerve conduits for anti-inflammatory and antioxidant effects. RSC Advances. 15(18). 14136–14151. 1 indexed citations
5.
Luo, Ying, et al.. (2024). Metal–organic framework-based pH/NIR dual-responsive nanoparticles for combined photothermal/photodynamic therapy and chemotherapy of cancer. New Journal of Chemistry. 48(19). 8773–8788. 4 indexed citations
6.
Wang, Sining, et al.. (2023). Poly(β-amino ester) Dual-Drug-Loaded Hydrogels with Antibacterial and Osteogenic Properties for Bone Repair. ACS Biomaterials Science & Engineering. 9(4). 1976–1990. 13 indexed citations
7.
Xie, Xiaohu, Jun Gu, Tingting Wu, et al.. (2023). Association of GABA receptor delta subunit gene variations with increased risk of methamphetamine dependence. Neuroscience Letters. 800. 137137–137137. 2 indexed citations
8.
Luo, Ying, Jia Liu, Lihua Huang, et al.. (2023). A pH/ROS dual-responsive nanoparticle system for tumor targeting combined chemotherapy/phototherapy. New Journal of Chemistry. 47(7). 3395–3405. 7 indexed citations
9.
Chen, Qi, Huanqing Li, Kai Yang, et al.. (2023). Transition‐metal‐free Cyclization of Mucohalic Acids with Sulfonyl Hydrazides: An Approach to Pyridazin‐3(2H)‐ones. Asian Journal of Organic Chemistry. 12(11).
10.
Zeng, Yawen, Jia Liu, Yiming He, et al.. (2021). PEGylated Nanoscale Metal–Organic Frameworks for Targeted Cancer Imaging and Drug Delivery. Bioconjugate Chemistry. 32(10). 2195–2204. 29 indexed citations
11.
Xu, Wenjin, Hong Ma, Jianbin Zhang, et al.. (2021). Increased Expression of Plasma miRNA-320a and let-7b-5p in Heroin-Dependent Patients and Its Clinical Significance. Frontiers in Psychiatry. 12. 679206–679206. 14 indexed citations
12.
Xu, Wenjin, Ming Zhao, Zi Lin, et al.. (2020). Increased expression of plasma hsa‐miR‐181a in male patients with heroin addiction use disorder. Journal of Clinical Laboratory Analysis. 34(11). e23486–e23486. 9 indexed citations
13.
Chen, Zhongxing, Mei Yang, Qing Wang, et al.. (2020). Hydrogel eye drops as a non-invasive drug carrier for topical enhanced Adalimumab permeation and highly efficient uveitis treatment. Carbohydrate Polymers. 253. 117216–117216. 23 indexed citations
14.
Li, Jingfa, Wenjin Xu, Lei Zhang, & Min Li. (2017). General Approach to Prepare 0.33Li2MnO3 · 0.67LiNi1/3Co1/3Mn1/3O2 Hollow Microspheres for High Performance Lithium Ion Batteries. Journal of Nanoscience and Nanotechnology. 18(6). 4127–4134. 2 indexed citations
15.
Xing, Bo, et al.. (2014). Effect of microinjecting of 5-aza-2-deoxycytidine into ventrolateral orbital cortex on depressive-like behavior in rats. Neuroscience Letters. 574. 11–14. 22 indexed citations
16.
Xu, Wenjin, Xianran He, Min Zhong, Xianming Hu, & Yuling Xiao. (2014). A novel pH-responsive hydrogel based on natural polysaccharides for controlled release of protein drugs. RSC Advances. 5(5). 3157–3167. 25 indexed citations
17.
Xu, Wenjin, Yan Zhao, Fu‐Quan Huo, Jing Du, & Jingda Tang. (2013). Involvement of ventrolateral orbital cortex 5-HT 1–7 receptors in 5-HT induced depression of spared nerve injury allodynia. Neuroscience. 238. 252–257. 25 indexed citations
18.
Xu, Wenjin, Imtiaz A. Siddiqui, Minakshi Nihal, et al.. (2013). Aptamer-conjugated and doxorubicin-loaded unimolecular micelles for targeted therapy of prostate cancer. Biomaterials. 34(21). 5244–5253. 177 indexed citations
19.
Xu, Wenjin, et al.. (2013). Cerebral Microvascular Rather than Parenchymal Amyloid-β Protein Pathology Promotes Early Cognitive Impairment in Transgenic Mice. Journal of Alzheimer s Disease. 38(3). 621–632. 41 indexed citations
20.
Xu, Wenjin, et al.. (2008). Asymmetric reduction of acetophenone using α,α-disubstituted aziridinemethanols and borane. Journal of Molecular Catalysis A Chemical. 300(1-2). 25–28. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026